Engineered CRISPR-Cas9 nucleases with altered PAM specificity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11859220
APP PUB NO 20220145275A1
SERIAL NO

17456092

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Engineered CRISPR-Cas9 nucleases with altered and improved PAM specificities and their use in genomic engineering, epigenomic engineering, and genome targeting.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE GENERAL HOSPITAL CORPORATION55 FRUIT STREET BOSTON MA 02114

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Joung, J Keith Winchester, US 101 2596
Kleinstiver, Benjamin Boston, US 32 438

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 2, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00